Literature DB >> 5443533

Fluorinated pyrimidines. 38. The incorporation of 5-trifluoromethyl-2'-deoxyuridine into the deoxyribonucleic acid of vaccinia virus.

Y Fujiwara, C Heidelberger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5443533

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


× No keyword cloud information.
  12 in total

1.  HEp-2 cell- and herpes simplex virus type 1- induced deoxythymidine kinases: inhibition by derivatives of 5-trifluoromethyl-2'-deoxyuridine.

Authors:  B L Wigdahl; J R Parkhurst
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

2.  Breakdown of HeLa cell DNA mediated by vaccinia virus.

Authors:  J R Parkhurst; A R Peterson; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

3.  Mechanism of selective inhibition of human cytomegalovirus replication by 1-beta-D-arabinofuranosyl-5-fluorouracil.

Authors:  S Suzuki; M Saneyoshi; C Nakayama; Y Nishiyama; S Yoshida
Journal:  Antimicrob Agents Chemother       Date:  1985-08       Impact factor: 5.191

4.  New active drugs for the treatment of advanced colorectal cancer.

Authors:  Alberto Zaniboni
Journal:  World J Gastrointest Surg       Date:  2015-12-27

Review 5.  Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

6.  Activity of trifluorothymidine against cytomegalovirus.

Authors:  J R Wingard; R K Stuart; R Saral; W H Burns
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

Review 7.  Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.

Authors:  Godefridus J Peters
Journal:  Ther Adv Med Oncol       Date:  2015-11       Impact factor: 8.168

8.  Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumours.

Authors:  T Doi; A Ohtsu; T Yoshino; N Boku; Y Onozawa; A Fukutomi; S Hironaka; W Koizumi; T Sasaki
Journal:  Br J Cancer       Date:  2012-06-26       Impact factor: 7.640

9.  Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.

Authors:  Takayuki Yoshino; Takashi Kojima; Hideaki Bando; Tomoko Yamazaki; Yoichi Naito; Hirofumi Mukai; Nozomu Fuse; Koichi Goto; Yuko Ito; Toshihiko Doi; Atsushi Ohtsu
Journal:  Cancer Sci       Date:  2016-03-28       Impact factor: 6.716

10.  5-Fluorouracil affects assembly of stress granules based on RNA incorporation.

Authors:  Christian Kaehler; Jörg Isensee; Tim Hucho; Hans Lehrach; Sylvia Krobitsch
Journal:  Nucleic Acids Res       Date:  2014-04-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.